Fear and Stigma of COVID-19 Reinfection Scale (FSoCOVID-19RS): New Scale Development and Validation

Author:

Albikawi Zainab Fatehi1ORCID,Abuadas Mohammad Hamdi1ORCID,Alalyani Mesheil M.2,Zahrani Yousef3ORCID,Aqel Emad1,Safi Raid4

Affiliation:

1. Community and Psychiatric/Mental Health Nursing Department, Nursing College, King Khalid University, Khamis Mushait 39746, Saudi Arabia

2. Medical Surgical Nursing Department, Nursing College, King Khalid University, Khamis Mushait 39746, Saudi Arabia

3. Public Health Department, College of Applied Medical Sciences, King Khalid University, Khamis Mushait 62529, Saudi Arabia

4. Basic Nursing Care Department, Nursing College, King Khalid University, Khamis Mushait 39746, Saudi Arabia

Abstract

Background: The advent of COVID-19 and its impacts have prompted fear and stigma among people all across the world. Because of stigma, there was often a delay in diagnosis and treatment, which resulted in a poor prognosis. As a result, a reliable scale is required to measure the level of fear and stigma of COVID-19 reinfection. Aim: To develop and validate a scale for determining the level of fear and stigma of COVID-19 reinfection. Methods: A cross-sectional study including 200 nursing-college students who had previously tested positive for COVID-19 was conducted. The scale’s reliability was evaluated by external and internal consistency methods. Construct, convergent, and discriminant validity were evaluated using exploratory factor analysis (EFA) and confirmatory factor analysis (CFA). Results: The scale’s mean score was 24.85 ± 11.35, and no floor or ceiling effects were detected. The scale items’ reliability, measured by Cronbach’s alpha coefficient if an item was deleted, ranged from 0.76 to 0.95, with a total score value of 0.86. The range of convergent validity coefficients was between 0.37 and 0.64. Pearson’s correlation coefficients for test–retest validity ranged from 0.71 to 0.93, with a total score of 0.82. The coefficient of split-half correlation was 0.87, while the coefficient of reliability was 0.93. According to the factor analysis, two components had latent roots larger than 1. The rotated component matrix of the two factors revealed that all items had R values over 0.30, indicating that none of them should be excluded. In addition, CFA results revealed that χ2 = 3524, df = 1283, χ2/df ratio = 2.74, p < 0.001, GFI = 0.86, CFI = 0.92, AGFI = 0.88, and RMSEA = 0.05. The scale’s convergent and discriminant validity was confirmed. Conclusions: The 14-item, two-dimensional Fear and Stigma of COVID-19 Reinfection Scale (FSoCOVID-19 RS) was demonstrated to have reliable psychometric properties.

Funder

the Deanship of Scientific Research at King Khalid University

Publisher

MDPI AG

Subject

Health Information Management,Health Informatics,Health Policy,Leadership and Management

Reference58 articles.

1. Organization, W.H (2020). Coronavirus Disease (COVID-19): Weekly Epidemiological, Update 1, World Health Organization.

2. Social reaction toward the 2019 novel coronavirus (COVID-19);Lin;Soc. Health Behav.,2020

3. Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity;Yahav;Clin. Microbiol. Infect.,2021

4. What reinfections mean for COVID-19;Iwasaki;Lancet Infect. Dis.,2021

5. Fear of COVID-19 Reinfection;Chaudhury;Acta Sci. Neurol.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3